So let’s get into it. Here’s everything you need to know to address uncommon UC symptoms and seize back control of your ...

Cosmo Pharmaceuticals on Friday reported the renewal of its multi-year manufacturing and supply agreement with Takeda (TAK), ...

Juvenile idiopathic arthritis, older age, and concomitant immunomodulation delay the onset of psoriasiform dermatitis in ...

Microbiotica has completed patient recruitment for its phase 1b trial, COMPOSER-1, evaluating MB310 in adults with ulcerative ...

AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis (UC) after a phase 2 study revealed ...

“These results represent a significant milestone for PALI-2108,” said JD Finley, Chief Executive Officer of Palisade Bio. “The early clinical activity, targeted delivery, dose flexibility, the ...

Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of its multi-year manufacturing and supply agreement with ...

The interaction between a common gene variant and gut microbes may trigger chronic inflammation in ulcerative colitis, new research suggests.

Cosmo Pharma & Takeda renew strategic manufacturing pact for global supply of oral treatment for ulcerative colitis: Dublin, Ireland Saturday, August 9, 2025, 15:00 Hrs [IST] Cosm ...

Patients with inflammatory bowel disease (IBD) have a 48% greater relative risk of developing interstitial lung disease (ILD) ...

Dawson's Creek actor James van der Beek shares how subtle bowel changes were the first warning sign of his stage 3 colorectal ...